TET2 and hematocrit: Among the potentially pathogenic changes predicted in CLP cells, TET2 mutation is the most frequent, seen in three of the four cases with divergent evolution of metachronous lymphomas, as well as in two of those with prior or subsequent biopsy showing HT.